BioElectronics to Present at 2017 UK Community Pha
Post# of 617763
FREDERICK, MD--(Marketwired - Jun 30, 2017) - BioElectronics Corporation (
This meeting brings together independent and small-chain pharmacists for a one-day event, scheduled to be held at the London Olympia in London, England on July 2nd. Dr. Koneru's presentation is designed to help pharmacists understand how they can use ActiPatch® Musculoskeletal Pain Therapy to help relieve their patients' chronic pain even when other therapies have failed. ActiPatch therapy is based on the newest understanding of chronic pain: chronic pain often results because nerves "learn" pain, a process known as central sensitization.
Providing new information to hyperactive nerves is essential in "resetting" pain tolerance thresholds. ActiPatch is a wearable medical device that regulates nerve activity (neuromodulation) 24/7 by providing safe, no-sensation electromagnetic pulses. This results in reduced nerve hyperactivity, thus resetting pain thresholds and providing effective pain relief. The devices are available in the United Kingdom pharmacies without a prescription for £24.99, including VAT, for the 720-Hour device.
About BioElectronics Corporation
BioElectronics Corporation distributes its ActiPatch Musculoskeletal Pain Therapy in UK pharmacies and is a leader in non-invasive electroceuticals. It develops, manufactures and markets disposable, drug-free, pain therapy devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; Allay® Menstrual Pain Therapy. For more information, please visit www.bielcorp.com .
About Pharmacy Forward In association with newly relaunched magazine, The Pharmacist, the team behind Pharmacy Forward are dedicated to delivering an event that gives independent pharmacists a voice, the answers and a clear pathway in this turbulent time.
Paul Knopick 940.262.3584 pknopick@eandecommunications.com
(0)
(0)